Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/eurheartj/ehaa391 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series.
Open Access Emerg Med
January 2025
Nuclear Medicine Department, Center of Nuclear Medicine and Oncology, Semey, Abay Region, Kazakhstan.
Background: One of the most serious complications of coronary artery stenting is restenosis and in-stent thrombosis; their prevalence can reach 20-25%. Stent thrombosis can be acute (up to 24 hours), subacute (24 hours to 30 days), late (30 days to 1 year), and very late (> 1 year after previous stenting). In the patients with COVID-19 in intensive care units, the proportion of those with elevated troponin levels reached 25%.
View Article and Find Full Text PDF[The modified hugging balloon technique].
G Ital Cardiol (Rome)
November 2024
S.C. Cardiologia, Ospedale S.G. Bosco, ASL Città di Torino, Torino.
Article Synopsis
- Percutaneous coronary intervention (PCI) has greatly improved treatments for coronary artery disease, but in-stent restenosis (ISR) remains a significant issue, especially when complicated by calcification.
- Various techniques exist for treating calcified ISR, including super-high-pressure balloon dilation, atherectomy methods, and intravascular lithotripsy (IVL).
- This case report discusses a patient with severe, calcified ISR in a large artery, showcasing the use of shockwave lithotripsy combined with balloon dilation to improve stent expansion, highlighting the effectiveness of innovative approaches for difficult ISR cases.
Clinical Impact of Intracoronary Imaging in the Management of Stent Thrombosis.
J Clin Med
August 2024
Cardiology Department, Essex Cardiothoracic Centre, Basildon SS16 5NL, UK.
Article Synopsis
- * Out of 130 patients with definite ST, 45 underwent ICI, and the analysis found that ICI-guided management improved survival rates free of cardiac death or target lesion revascularization (CD-TLR) at 2 years to 93% compared to 73% for those not guided by ICI.
- * The results suggest that ICI can significantly influence treatment decisions, leading to better outcomes in patients with ST, particularly by identifying the main mechanisms causing thrombosis.
Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis: The RIBS VI Study.
JACC Cardiovasc Interv
August 2024
Hospital Universitario de La Princesa, Madrid, Spain. Electronic address:
Background: In patients with in-stent restenosis (ISR) bioresorbable vascular scaffolds (BVS) provide similar results to drug-coated balloons (DCBs) but are inferior to drug-eluting stents (DES) at 1 year. However, the long-term efficacy of BVS in these patients remains unknown.
Objectives: This study sought to assess the long-term safety and efficacy of BVS in patients with ISR.
Comparison of Neoatherosclerosis and Neovascularization of Restenosis after Drug-Eluting Stent Implantation: An Optical Coherence Tomography Study.
Rev Cardiovasc Med
December 2023
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, 563000 Zunyi, Guizhou, China.
Background: Neoatherosclerosis (NA) is associated with stent failure. However, systematic studies on the manifestations of NA and neovascularization (NV) at different stages after drug-eluting stent (DES) implantation are lacking. Moreover, the relationship between NA and NV in in-stent restenosis (ISR) has not been reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!